Retraction:
Retraction: Downregulation of X-linked inhibitor of apoptosis protein by ‘7-Benzylidenenaltrexone maleate’ sensitizes pancreatic cancer cells to TRAIL-induced apoptosis
Metrics: PDF 96 views | ?
1 ASAN Institute for Life Sciences, ASAN Medical Center, Seoul, 05505, South Korea
2 Department of Convergence Medicine, University of Ulsan College of Medicine, Seoul, 05505, South Korea
3 Department of Biomedical Sciences, University of Ulsan College of Medicine, Seoul, 05505, South Korea
4 Division of HBP Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, 05505, South Korea
Published: December 31, 2025
Copyright: © 2025 Kim et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been retracted: The journal initiated an investigation into this paper after the authors requested a correction for six Western blot images (Figures 2A, 3A, 5A–5C, and Supplementary Figure 3B) without providing a detailed explanation of the errors. Our investigation found two instances of image duplication:
- The “α-Tubulin” blot in Figure 2A was rescaled and reused as the “α-Tubulin” blot in Figure 5C.
- The “Survivin” blot in Figure 3A is a reuse of the “p-CDK9 (T186)” blot previously published in Figure 5C of an earlier article from the same research group [1].
The authors were contacted for comment but did not respond. Due to the number and nature of these issues, the editorial decision was made to retract this paper.
REFERENCES
1. Kim SY, Park SE, Shim SM, Park S, Kim KK, Jeong SY, Choi EK, Hwang JJ, Jin DH, Chung CD, Kim I. Bay 61-3606 Sensitizes TRAIL-Induced Apoptosis by Downregulating Mcl-1 in Breast Cancer Cells. PLoS One. 2015; 10:e0146073. https://doi.org/10.1371/journal.pone.0146073.. [PubMed].
Original article: Oncotarget. 2017; 8:61057–61071. DOI: https://doi.org/10.18632/oncotarget.17841.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28813
